US firm to launch “revolutionary” portable AI ultrasound device in Bangladesh

An important advancement in Bangladesh’s healthcare system will be made when a US-based business announces intentions to launch a “revolutionary” portable AI-powered ultrasound gadget there.

Today at the State Guest House in Jamuna, Exo Imaging officials, led by co-founders Yusuf Haque and Sandeep Akkaraju, met with Chief Adviser Professor Muhammad Yunus to talk about the innovative technology and its possible implications.

Exo’s Chief Technology Officer, Yusuf Haque, a US medical technology specialist of Bangladeshi descent, stated that the business intends to introduce the gadget first in top hospitals throughout Bangladesh with the long-term goal of extending access to community and rural healthcare facilities.

“This device is designed to be portable and highly efficient, making high-quality diagnostics more accessible, even in remote areas,” he said.

“It will revolutionise healthcare across the globe, especially in places like rural Bangladesh. Doctors and nurses will soon use it like a stethoscope,” Haque added.

Sandeep Akkaraju, Chief Executive Officer of Exo, stated that Bangladesh is the first country in Asia to adopt the technology, which is currently only available in the United States under approval from the US Food and Drug Administration (FDA).

“We are also planning to launch it in Mexico and several Latin American countries soon,” Akkaraju added.

The AI-powered portable ultrasound device can assist in the early detection of a wide range of conditions, including heart disease, tuberculosis, breast cancer, lung disease, thyroid issues, and pregnancy-related complications.

Chief Adviser Professor Muhammad Yunus welcomed the initiative, calling it a major step toward achieving universal healthcare access.

“It sounds like science fiction,” he remarked. “AI plays a remarkable role in healthcare. As we know, treatment begins with diagnosis. Patients often become more ill while waiting for tests. This technology can help reduce that burden by bringing diagnostics closer to the patient,” the Chief Adviser said. 

Highlighting the device’s portability, Haque said, “Doctors and health workers can take the device directly to patients, removing the need for long waits or travel.”

Omar Ishrak, a board member at Exo and a former chairman of Intel Corporation, noted, “This is a game changer for countries like Bangladesh. Around 80 per cent of the world’s population lacks access to quality healthcare. This kind of technology can help close that gap.”

“Patients with chronic illnesses such as breast cancer need frequent screenings. This device makes that process more convenient. It’s essentially the next-generation stethoscope — a powerful tool that provides instant, AI-driven diagnostic insights,” he said.

Akkaraju also shared that Exo is developing complementary software to help healthcare workers prioritise patients based on urgency, send follow-up reminders, and streamline communication between patients and providers.

“This is the next stage of telemedicine,” he said.

Special Assistant to the Chief Adviser Sayedur Rahman, BIDA Executive Chairman Chowdhury Ashik Mahmud Bin Harun and Senior Secretary for SDG Affairs Lamiya Morshed were present at the meeting, among others. 

This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]
No Comments

Leave a Reply

*

*